VST-1001

dilute fluorescein · Vestan, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VST-1001, covering 2015-07-27 to 2015-07-27. Get the full timeline:

Most recent: Clinical Trial Update: VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer [Phase 1, Phase 2]

See pricing